Insider Purchases: Inside the Buy

Tag: AI

Digital lock interface glowing with AI circuitry, surrounded by floating user identities and bot avatars, with a rising stock chart subtly embedded in the background symbolizing Okta’s identity security growth in the AI era

🛡️ Okta (OKTA): The AI Identity Moat Is Getting Cheaper

Okta is no longer just a high-growth story—it’s becoming a profitable identity powerhouse in the age of AI. With improving margins, strong institutional backing, and a new insider buy, the question is simple: is this a turnaround… or just the beginning?

Read entire article

Tags: AgenticSecurity, AI, ai cybersecurity, buy or sell OKTA, Cybersecurity, cybersecurity investing, FUNanc1al, funanc1al tech hub, growth at a discount, hub-insiders, identity security stocks, IdentitySecurity, insider buying, OKTA, okta analysis 2026, okta stock, OktaStock, risks buying OKTA, saas stocks, StockMarket2026, tech turnaround stocks, why buy OKTA
Cartoon-style illustration of Salesforce cloud logo with rocket boosters, symbolizing insider buys, AI growth, and potential stock lift-off.

Salesforce (CRM): Insider Buys, AI Clouds, and Customer Armies — Should You Join the Ride?

Salesforce insiders are buying, AI is booming, and institutions are all-in. But is CRM stock really ready to rebound — or just blowing more cloud smoke? ☁️💸

 

Read entire article

Tags: AI, AI Investing, AI Investments, CloudComputing, CRM, CRM Stock, DIrector Buying, Director Insider Buying, Funanc1al, Funanc1al investing, hub-hedge, hub-insiders, InsiderBuying, Investing, Salesforce, StockMarket, TechStocks, WallStreet
Digital illustration of a DNA strand fusing with glowing AI circuitry inside a futuristic lab, symbolizing Absci’s generative AI drug discovery technology.

Absci: When AI Meets Antibodies — and Insiders Can’t Resist Buying More!

AI is designing drugs, and Absci is leading the charge — with insider confidence, top-tier partners, and a cash runway through 2028. Still pre-revenue but packed with promise, this biotech might just be the next NVIDIA of antibodies.

Read entire article

Tags: Absci, ABSI, ABSI Stock, AI, AI in Biotech, AI Stocks, Almirall, AMD, Ark Invest, Biotech, Biotech Humor, Biotech Innovation, Biotech Investing, Biotech Investments, Biotech Partnerships, Biotech Stocks, Buy ABSI Stock, CFO Bought Shares, CFO Insider Buying, CFOBuyIn, Chief Innovation Officer Buying Shares, Director Insider Buying, drug discovery, FMR, Funanc1al, Funanc1al Edge, insider purchases, institutional ownership, investing humor, Oracle, Redmile Group, speculative stocks